Danaher (DHR) stock
Last close $220.36 on 2026-11-20 (-3.16%) · Sector: Healthcare
Danaher is a large American healthcare company that makes and sells tools, instruments, and testing products used in hospitals, labs, and drug and biotech companies. It earns most of its money by selling equipment, reagents, and consumable supplies, plus service contracts that keep that equipment running.
Danaher's business is still profitable and its revenue grew 5.5% over the past year, though its latest quarter's revenue was about $6.6 billion. Over the past year the stock returned -3.1%, while the S&P 500 returned 4.67%, so it has lagged the broader market. The stock is 2.0% below its 50-day average and 9.5% above its 200-day average, and it sits 9.2% below its 52-week high. Insiders sold about $13.4 million of stock over the last 90 days and bought none, and the stock has more often fallen than risen the day after earnings.
Key numbers
- Market cap: $155.8B
- Revenue (last 12 months): $25.60B
- Revenue growth: +5.5%
- Gross margin: 58.6%
- Operating margin: 20.4%
- P/S: 6.1
- Debt to equity: 0.45
- Current ratio: 1.63
Quality score
Overall 44/100 · growth 34 · profitability 44 · financial health 55 · value None
Performance and risk
1-year return -3.1% vs S&P 500 +4.7% · volatility 30.7% (S&P 500 14.3%) · largest drop -33.1% · beta 0.58
Stock move the day after earnings
- 2026-01-12: +0.3%
- 2026-01-28: -2.2%
- 2026-04-21: -5.4%
- 2026-07-21: +0.1%
- 2026-10-21: -1.8%
Congress trades (90 days)
1 buys, 2 sells
Insider trades (12 months)
Bought $0.0M · sold $36.0M
DHR stock research · DHR options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.